Inflammatory Bowel Disease

Inflammatory Bowel Disease

Inflammatory bowel disease, which encompasses Crohn’s disease and ulcerative colitis, has undergone a transformation in management over the last decade. Early treatment to achieve mucosal healing and complete resolution of symptoms have become overarching treatment goals for IBD. The advent of a range of biologic drugs, in addition to a growing understanding of IBD pathogenesis and related comorbidities, highlight the need for CME that is current and practice-changing. Clinical Care Options provides up-to-date and evidence-based IBD CME that arms physicians, nurses, pharmacists, and other health care providers with the necessary tools to optimize care of their patients with IBD. Choose from a range of IBD CE courses in a variety of formats designed to deliver the most relevant information in the most accessible manner possible.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings